- Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
- Cavco Industries Reports Fiscal 2026 Fourth Quarter and Year End Results
- Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three Months Ended March 31, 2026
- Stellantis Presents FaSTLAne 2030 Financial Framework & Targets at Investor Day 2026
- WSO2 Accelerates Agentic Enterprise Adoption with New Agent Identity, Forward Deployed Engineers, and Expanded Delivery Partner Ecosystem
- Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
- Stellantis and Applied Intuition Expand Collaboration with STLA Brain to Advance Vehicle Software and Enhance Customer Experience
- Arqit Quantum Inc. Announces Financial Results for First Half of Fiscal Year 2026
- Stellantis Unveils €60 Billion Strategic Plan to Accelerate Growth and Profit
- Nocopi Technologies Expands Operations with Acquisition of Polymeric and Appointment of Industry Executive
- Alamos Gold Announces Management Appointments
- Final results for the financial year ended 31 March 2026
- Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
- Skyworks Commences Exchange Offers and Consent Solicitations for Qorvo’s Senior Notes due 2029 and 2031
- Banzai International, Inc. Expands Market Reach, Announces Strategic Alliance with Ingram Micro
- 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
- Virtual Private Branch Exchange (PBX) System Global Market Analysis Report 2026: $21.98 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
- LZ Technology Holdings Limited Announces 1-for-20 Reverse Share Split
- Dynacor Group Announces Changes to Board of Directors
- Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026